BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9390670)

  • 1. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults.
    Simmons Z; Wald JJ; Albers JW
    Muscle Nerve; 1997 Dec; 20(12):1569-75. PubMed ID: 9390670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults.
    Simmons Z; Wald JJ; Albers JW
    Muscle Nerve; 1997 Aug; 20(8):1008-15. PubMed ID: 9236792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy.
    Simmons Z; Albers JW; Bromberg MB; Feldman EL
    Brain; 1995 Apr; 118 ( Pt 2)():359-68. PubMed ID: 7735878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
    Gorson KC; Allam G; Ropper AH
    Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Hahn AF
    Neurology; 1998 Dec; 51(6 Suppl 5):S16-21. PubMed ID: 9851725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    Van Doorn PA
    Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and electrophysiological correlation in chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin therapy: a case report.
    Han NH; Huang CC; Tsai CP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):42-6. PubMed ID: 9134822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin.
    Choudhary PP; Hughes RA
    QJM; 1995 Jul; 88(7):493-502. PubMed ID: 7633875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in chronic relapsing polyneuropathy.
    Tuohy PG
    N Z Med J; 1992 Feb; 105(928):60-1. PubMed ID: 1311826
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments.
    Nemni R; Amadio S; Fazio R; Galardi G; Previtali S; Comi G
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):43-5. PubMed ID: 7964852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
    Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
    [No Abstract]   [Full Text] [Related]  

  • 15. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series.
    McMillan HJ; Kang PB; Jones HR; Darras BT
    Neuromuscul Disord; 2013 Feb; 23(2):103-11. PubMed ID: 23140945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
    Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
    Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins.
    Bentes C; de Carvalho M; de Sá J; Luís ML
    Electromyogr Clin Neurophysiol; 1999; 39(1):33-7. PubMed ID: 10076759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
    Simmons Z; Albers JW; Bromberg MB; Feldman EL
    Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy".
    Berger AR; Herskovitz S; Kaplan J
    Muscle Nerve; 1995 Apr; 18(4):440-4. PubMed ID: 7715630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
    Cortese A; Franciotta D; Alfonsi E; Visigalli N; Zardini E; Diamanti L; Prunetti P; Osera C; Gastaldi M; Berzero G; Pichiecchio A; Piccolo G; Lozza A; Piscosquito G; Salsano E; Ceroni M; Moglia A; Bono G; Pareyson D; Marchioni E
    J Neurol Sci; 2016 Apr; 363():182-7. PubMed ID: 27000248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.